Isabel R Schlaepfer Selected Research

etomoxir

1/2020	Targeting Fatty Acid Oxidation to Promote Anoikis and Inhibit Ovarian Cancer Progression.
1/2018	A novel approach to target hypoxic cancer cells via combining β-oxidation inhibitor etomoxir with radiation.
10/2014	Lipid catabolism via CPT1 as a therapeutic target for prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Isabel R Schlaepfer Research Topics

Disease

24	Neoplasms (Cancer) 04/2022 - 11/2012
13	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2014
3	Hypoxia (Hypoxemia) 12/2021 - 09/2015
2	Tobacco Use Disorder (Nicotine Dependence) 05/2012 - 06/2008
1	Melanoma (Melanoma, Malignant) 04/2022
1	Carcinogenesis 04/2022
1	Ovarian Neoplasms (Ovarian Cancer) 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Adenocarcinoma of Lung 01/2018
1	Urinary Bladder Neoplasms (Bladder Cancer) 07/2017
1	Circulating Neoplastic Cells 01/2017
1	Breast Neoplasms (Breast Cancer) 11/2012
1	Conduct Disorder (Conduct Disorders) 06/2007
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 06/2007
1	Insulin Resistance 06/2003

Drug/Important Bio-Agent (IBA)

12	LipidsIBA 04/2022 - 06/2003
6	Fatty Acids (Saturated Fatty Acids)IBA 04/2022 - 06/2003
4	Pharmaceutical PreparationsIBA 01/2021 - 05/2012
4	EnzymesIBA 11/2020 - 11/2012
3	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2017
3	etomoxirIBA 01/2020 - 10/2014
3	enzalutamideIBA 05/2019 - 08/2017
2	SphingomyelinsIBA 04/2022 - 01/2018
2	Hormones (Hormone)IBA 01/2022 - 01/2014
2	Carnitine O-Palmitoyltransferase (Carnitine Palmitoyltransferase II)IBA 12/2021 - 01/2020
2	Ranolazine FDA Link 12/2020 - 08/2017
2	AndrogensIBA 05/2019 - 01/2019
1	lysophosphatidic acidIBA 04/2022
1	Trinitrotoluene (TNT)IBA 04/2022
1	SteroidsIBA 01/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 12/2021
1	Cyclin D1IBA 12/2021
1	Vascular Endothelial Growth Factor DIBA 12/2021
1	pimonidazoleIBA 12/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2021
1	CholesterolIBA 11/2021
1	TransferasesIBA 11/2020
1	Carnitine (L-Carnitine)FDA LinkGeneric 11/2020
1	AntioxidantsIBA 11/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2020
1	Mitogen-Activated Protein KinasesIBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020
1	TubulinIBA 01/2018
1	SphingolipidsIBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2018
1	Androgen Antagonists (Antiandrogens)IBA 08/2017
1	Protein Isoforms (Isoforms)IBA 08/2017
1	GoldIBA 07/2017
1	LuciferasesIBA 07/2017
1	ErbB Receptors (EGF Receptor)IBA 07/2017
1	Antineoplastic Agents (Antineoplastics)IBA 07/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	Keratins (Keratin)IBA 01/2017
1	Glutamine (L-Glutamine)FDA Link 07/2016
1	Triglycerides (Triacylglycerol)IBA 09/2015
1	Indicators and Reagents (Reagents)IBA 09/2015
1	Glucose (Dextrose)FDA LinkGeneric 08/2015
1	Orlistat (Xenical)FDA Link 10/2014
1	MetriboloneIBA 01/2014
1	Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric 01/2014
1	Testosterone CongenersIBA 01/2014
1	Progesterone Receptors (Progesterone Receptor)IBA 11/2012
1	stearoyl-coenzyme A (stearoyl-CoA)IBA 11/2012
1	Progestins (Progestagens)IBA 11/2012
1	Docetaxel (Taxotere)FDA Link 11/2012
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 06/2008
1	protein kinase C gamma (PRKCG)IBA 06/2007
1	Munc18 ProteinsIBA 06/2003
1	Proteins (Proteins, Gene)FDA Link 06/2003

Therapy/Procedure

10	Therapeutics 04/2022 - 11/2012
1	Oral Administration 12/2020
1	Castration 01/2019
1	Radiotherapy 01/2018
1	Lasers (Laser) 07/2017
1	Cystoscopes 07/2017
1	Drug Therapy (Chemotherapy) 01/2014